Beckman Agreement Will Give Biosite Automated Platform For BNP Assay

Biosite will leverage Beckman Coulter's U.S. installed base of automated immunoassay analyzers to grow its market share in BNP testing under a long-term development deal between the firms

More from Archive

More from Medtech Insight